Texans place OL David Quessenberry on reserve/non-football injury list

Houston Texans offensive tackle David Quessenberry takes the field during a voluntary veteran football mini-camp Wednesday, May 7, 2014, in Houston. (AP Photo/Pat Sullivan)

Earlier this month, offensive lineman David Quessenberry said that he felt strong as he worked to make it back on the field after his football career was halted by a diagnosis of non-Hodgkins lymphoma in June 2014.

Quessenberry’s comeback effort has now been put on hold, after he was place on the reserve non-football injury list by the Houston Texans on Tuesday. 

Recommended Videos



He was waived with the non-football illness designation. 

"Basically we believed David Quessenberry wasn't going to be ready from a health standpoint to adequately compete this year," head coach Bill O'Brien said after the Texans latest on-field training session on Tuesday.

"So procedurally in order to gain the roster spot, we made the decision to place him on waivers with the designation of non-football illness," O'Brien said.

"It is our hope that he will revert to reserve/NFI so he can continue to be a part of our organization, continue his recovery and fulfill his goal of playing again," O'Brien added.

Quessenberry has cleared waivers and was moved to Texans reserve/non-football injury list.

He does not count against the 90-man roster limit.

"We want him to fully attack and beat cancer, which he will do," O'Brien said. "Then get him back on the 90-man roster at some point in 2017."

Quessenberry has been in remission for a year and had been steadily regaining weight and strength in hopes of making a return to the field. 

The third year player has yet to see action in an NFL game after his rookie season ended less than a week before the 2013 regular season opener when he injured his foot in practice and was placed on season-ending injured reserve. 

He's missed the last two seasons while battling cancer.

The Texans drafted Quessenberry in the sixth round of the 2013 draft out of  San Jose State University.